Video 6: Why Avilamycin is the responsible choice; WHO guidelines

In this episode, we will learn why Avilamycin is the responsible choice and WHO guidelines on animal use of medically important antimicrobials.

In 2017, the World Health Organization (WHO) published the Guidelines on use of Medically Important Antimicrobials in Food-Producing Animals. The objective of these guidelines is risk management of antimicrobial resistance due to non-human use.

The antimicrobials used should start with those of least importance for human health, e.g., start with classes not used in humans, and then as listed on the WHO CIA List.

Antimicrobials classified as critically important in human medicine on the WHO CIE List should be used only when the most recent culture and sensitivity results of bacteria know to have caused the disease indicate that the critically important antimicrobial is the only option.

2 important documents – The Ranking of MIA and Guidelines for Use of MIA and Food-Producing Animals – are available for use by policy-makers and government officials as well as veterinarians and livestock keepers as guidelines for responsible antimicrobial use.

Key learnings:

• Antimicrobial classes not used in humans = ‘Animal only‘
• Responsible use starts with ‘Animal only’ antimicrobials (e.g., Avilamycin)
• Avilamycin is the first-choice antimicrobial for necrotic enteritis control
• Choosing Avilamycin helps reduce the poultry industry’s reliance on medicines that are important for human health